BEUDAMED
    FDA Adverse Event Injury Summary report: N

    REMUNITY

    MDR report key: 19692321 · Received July 5, 2024

    Report

    Report Number
    MW5157095
    Event Type
    Injury
    Date Received
    July 5, 2024
    Report Date
    July 1, 2024
    Manufacturer
    UNK
    Product Code
    QJY
    Adverse Event
    Yes
    Report Source
    Voluntary report
    Reporter Occupation
    OTHER HEALTH CARE PROFESSIONAL
    Health Professional
    Yes

    Narratives

    Description of Event or Problem · 0

    PER COMMUNICATION FROM RN (B)(6) AT THE MD OFFICE: "PT OF DR. (B)(6) FROM (B)(6) ADMITTED TO (B)(6) FOR INFECTED ABDOMINAL SQ REMODULIN SITE. WE REDUCED HER REMODULIN TO 50NG/KG/MIN. DR. (B)(6) WILL HAVE TO DECIDE IF HE WANTS HER TO UPTITRATE." ONSET DATE OF SITE INFECTION IS UNKNOWN. DATE OF ADMITTANCE OR CURRENT LENGTH OF HOSPITALIZATION IS UNKNOWN. NO FURTHER INFO, DETAILS OR DATES AVAILABLE. SQ REMUNITY SELF-FILL PT. PT STARTED USING REMUNITY DEVICE ON (B)(6) 2023. REPORTED TO (B)(6) BY HEALTH PROFESSIONAL.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    1459414 REMUNITY INFUSION PUMP, DRUG SPECIFIC, PHARMACY-FILLED QJY UNK

    Patients

    Seq Age Sex Outcome Treatment
    1 NA Female Hospitalization SILDENAFIL CITRATE.